Medicinal products for human use: information on products subject to medical prescription

Proposal on information to the public on medicinal products for human use subject to medical prescription, amending Directive 2001/83/EC. Amendments set prior vetting of product-related information by the Agency or national competent authorities, time limits for objections, a publicly accessible multilingual database of authorised medicinal products including summaries of product characteristics and package leaflets, and the role of national authorities for internet websites.